Cargando…
Does inflammation help during COVID-19?
Persistent viral presence, rather than the early exaggerated inflammation, may be a key determinant of disease severity in #COVID19. If so, the focus of new therapies should be to promote viral clearance to decrease disease severity and mortality. https://bit.ly/3ahgzkP
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Respiratory Society
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553107/ https://www.ncbi.nlm.nih.gov/pubmed/33083436 http://dx.doi.org/10.1183/23120541.00557-2020 |